Physician profile
Mitchell L Horowitz
NPI 1639155609
$2,276.01
in general payments reported to CMS, 2019-2025
17 companies · $386 in 2025
The $386 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $472 · 2020: $110 · 2021: $90.03 · 2022: $423 · 2023: $523 · 2024: $271 · 2025: $386.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,180.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $356.25 | 2021-2025 | Oasis, Grafix |
| Abbvie INC. | $244.00 | 2022-2023 | |
| Wright Medical Technology, INC. | $243.95 | 2019 | |
| Paratek Pharmaceuticals, INC. | $220.90 | 2024-2025 | Nuzyra |
| Janssen Biotech, INC. | $152.01 | 2022-2023 | Symtuza |
| Nevro Corp. | $148.80 | 2023 | Senza |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $148.65 | 2023 | Jublia |
| Amgen INC. | $125.00 | 2025 | Krystexxa |
| Averitas Pharma INC. | $122.19 | 2024 | Qutenza |
| Baxter Healthcare | $117.61 | 2019 | |
| Celularity INC. | $110.41 | 2020 | |
| Zimmer Biomet Holdings, INC. | $110.29 | 2019 | |
| Advanced Oxygen Therapy INC. | $100.00 | 2022 | |
| Alkermes, INC. | $25.48 | 2024 | Vivitrol |
| Janssen Pharmaceuticals, INC | $23.21 | 2024 | Invega Sustenna |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $13.65 | 2022 | |
| Phadia US INC. | $13.61 | 2023 | Immunocap |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Horowitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.